Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Amortization of Deferred Charges (2016 - 2023)

Cartesian Therapeutics (RNAC) has disclosed Amortization of Deferred Charges for 9 consecutive years, with -$78000.0 as the latest value for Q3 2023.

  • For Q3 2023, Amortization of Deferred Charges fell 139.39% year-over-year to -$78000.0; the TTM value through Jun 2024 reached -$78000.0, down 108.6%, while the annual FY2023 figure was $455000.0, 52.26% down from the prior year.
  • Amortization of Deferred Charges hit -$78000.0 in Q3 2023 for Cartesian Therapeutics, down from $135000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $398000.0 in Q1 2023 and bottomed at -$78000.0 in Q3 2023.
  • Average Amortization of Deferred Charges over 5 years is $181157.9, with a median of $196000.0 recorded in 2022.
  • Year-over-year, Amortization of Deferred Charges soared 314.0% in 2021 and then crashed 139.39% in 2023.
  • Cartesian Therapeutics' Amortization of Deferred Charges stood at $64000.0 in 2019, then surged by 234.38% to $214000.0 in 2020, then decreased by 0.93% to $212000.0 in 2021, then fell by 16.98% to $176000.0 in 2022, then crashed by 144.32% to -$78000.0 in 2023.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at -$78000.0, $135000.0, and $398000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.